Status
Conditions
Treatments
About
Evaluation of adherence, persistence and efficacy of treatment with PCSK9 inhibitors in a real-life Italian population.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
2,000 participants in 1 patient group
Loading...
Central trial contact
Pasquale Perrone Filardi, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal